KETILEPT PROLONG 400 MG TBL PRO 30

What is the maximum co-payment for KETILEPT PROLONG?

If the insurance company contributes, the maximum co-payment is 454,61 Kč. The maximum pharmacy price is 902,60 Kč. A pharmacy may provide the medicine for a lower price, but not for a higher price.

Does the medicine have reimbursement from public health insurance?

Yes, zkontrolujte ale specializaci předepisujího lékaře níže.

Does KETILEPT PROLONG have a counted co-payment set?

No, this medicine has no counted co-payment.

How much does the insurance company pay for one dispensed reimbursed pack?

447,99 Kč.

Does the insurance company pay a higher amount in some cases?

No, the medicine has no increased reimbursement.

Does the medicine have an indication restriction?

The medicine has no indication restriction. Its reimbursement is not conditional on a specific diagnosis or clinical condition.

Is it available without a medical prescription?

No, the medicine cannot be obtained without a prescription.

Which medical specialist may prescribe KETILEPT PROLONG?

psychiatry, child and adolescent psychiatry, geriatric psychiatry

What is the composition of KETILEPT PROLONG?

Kvetiapin-fumarát (460,48 mg), kvetiapin (400 mg), neznámá látka s kódem 877, laktosa, neznámá látka s kódem 20629, ointmentek, magnesium-stearát, neznámá látka s kódem 9832. More information about the composition can be found in the SPC, section 6.1.

Where can I find information about correct use of the medicine?

Which medicines are similar to KETILEPT PROLONG?

The medicine belongs to ATC group N05AH04 – KVETIAPIN. Medicines with the same active substance can be found here.

Who manufactures KETILEPT PROLONG?

Egis Pharmaceuticals PLC, Budapešť (H)

Is the medicine in shortage?

The latest report from the manufacturer is from 18. 11. 2024. Production was terminated with effect from 29. 11. 2024. The manufacturer lists medicines with the following code as a potential substitute: